Massive Real-World study tracks targeted therapy success in early lung cancer
NCT ID NCT07593248
First seen May 18, 2026 · Last updated May 20, 2026 · Updated 1 time
Summary
This study will follow about 2,000 people in China who have a specific type of lung cancer (EGFR-mutated) and have had surgery. After surgery, they take a targeted pill (EGFR-TKI) to try to prevent the cancer from coming back. Researchers will track how long patients live and how long they stay cancer-free over 5 years, using real-world data from hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.